Moser, Tina http://orcid.org/0000-0001-5211-0920
Waldispuehl-Geigl, Julie
Belic, Jelena
Weber, Sabrina
Zhou, Qing
Hasenleithner, Samantha O. http://orcid.org/0000-0002-9401-5224
Graf, Ricarda
Terzic, Jasmin Alia
Posch, Florian
Sill, Heinz http://orcid.org/0000-0003-0993-4371
Lax, Sigurd http://orcid.org/0000-0002-3576-601X
Kashofer, Karl
Hoefler, Gerald
Schoellnast, Helmut
Heitzer, Ellen http://orcid.org/0000-0002-8815-7859
Geigl, Jochen B. http://orcid.org/0000-0001-9160-0682
Bauernhofer, Thomas http://orcid.org/0000-0001-9124-4876
Speicher, Michael R. http://orcid.org/0000-0003-0105-955X
Funding for this research was provided by:
Austrian Science Fund (KLI 764, KLI 710)
Article History
Received: 8 May 2020
Accepted: 21 October 2020
First Online: 13 November 2020
Competing interests
: The authors declare the following competing financial interests: E.H. and M.R.S. have an unrelated sponsored research agreement with Servier within CANCER-ID, a project funded by the Innovative Medicines Joint Undertaking (IMI JU). E.H. receives funding from Freenome, South San Francisco, CA and PreAnalytiX, Hombrechtikon, Switzerland. The other authors have no competing interests to declare.